A double-blind, within-patient trial was carried out to compare intramuscular pethidine 100 mg, epidural pethidine 50 mg and epidural bupivacaine 25 mg for pain relief on the day after caesarean section or lower abdominal gynaecological surgery. Analgesia was assessed on a visual analogue pain scale. Forced expiratory volume in one second (FEVI.O) and venous plasma catecholamine levels were measured immediately before and approximately thirty minutes after each treatment. At the completion of the study the treatments were ranked in order of patient preference. Nineteen patients completed the trial. Analgesia provided by epidural pethidine 50 mg was superior to intramuscular pethidine 100 mg (p <0.05) but not statistically better than epidural bupivacaine. There was no significant difference in the duration of analgesia between the active treatments. A mean increase in FEV 1 . O of 18% occurred after both of the epidural treatments, but this did not achieve statistical significance. There was no significant change in catecholamine levels after any of the treatments. Epidural pethidine was preferred by patients over and above intramuscular pethidine and epidural bupivacaine (p <0.05).
hours, and this regimen has been well received by patients and staff. A strong clinical impression of superiority over other commonly employed methods of providing postoperative analgesia had been gained, but we had no objective information to support this impression. The present study was therefore designed to investigate the efficacy and sideeffects of epidural pethidine compared with intramuscular pethidine and epidural bupivacaine in a double-blind trial. A withinpatient comparison was used in order that these treatments could be compared with each other, the patient acting as her own control. No such comparative study appears to have been reported previously.
In the presence of an abdominal wound, pain during exertion is greater than at rest. Forced expiratory volume in one second (FEV 1.0) for example has been shown to be severely restricted following abdominal surgery, and to be improved after receiving postoperative analgesia. 1 FEV 1.0 was therefore chosen as an indirect assessment of abdominal pain before and after each of the treatments.
Finally we were interested to see if catecholamine levels would be influenced by the three treatments used in the trial and thereby serve as another potential indicator of analgesic efficacy. Catecholamine levels -particularly noradrenaline -rise significantly in other stressful circumstances, e.g. following intubation,2 during surgery3.4 and intensive care therapy,5 but we are not aware of any studies in relation to postoperative pain.
MATERIALS AND METHODS
The investigation was approved by the Queen Victoria Hospital Research and Ethics Committee, and informed written consent was obtained from each patient. Twenty-three patients were included in the study, all of whom had received an epidural block for surgery on the previous day. Twelve patients had received a combined epidural and subarachnoid block for elective caesarean section. The remaining eleven patients had received an epidural block combined with light general anaesthesia (nitrous oxide/oxygen) for either tubal microsurgery or abdominal hysterectomy. The lumbar region was chosen for the insertion of the epidural catheter in all cases. Epidural pethidine 50 mg in saline 10 ml had been provided on a patient demand basis for postoperative analgesia in the first 24 hours after surgery, and prior to the beginning of the trial.
The present investigation was performed on the day following surgery, and after complete regression of neural blockade had occurred. A 25-gauge indwelling needle (Butterfly, Abbott) was inserted into a deltoid muscle on the lateral aspect of the arm at the beginning of the study. Each patient therefore had both intramuscular and epidural access. Four pairs of coded vials were supplied by the Pharmacy Department for each of the patients. One of these pairs (2 ml vial) was for intramuscular injection, and the other (10 ml vial) for epidural injection. The vial pairs were arranged in such a way that an active drug was always accompanied by a placebo (saline). One of the pairs contained saline in both vials, i.e. a 'double placebo'. The contents of each vial were known only to the Chief Pharmacist and were not revealed until the end of the trial. There were thus four treatments, as follows:
pethidine 100 mg saline saline bupivacaine 25 mg saline pethidine 50 mg saline saline Each patient would receive therefore four pairs of 'treatments' in random order and on a patient-demand basis. In the event that satisfatory analgesia was not achieved within 30 minutes, then the next treatment was given. Patients were free to withdraw from the trial at any stage. In other cases the trial was concluded after all four pairs of treatments had been given. The doses of pethidine and bupivacaine were chosen on the basis that they are commonly employed for providing postoperative analgesia in this institution.
Observations and Assessment
All observations and tests were performed by the same trained nurse observer throughout the trial. The patients remained in bed during the study but were not otherwise restricted. The patients were asked to assess their pain on a visual analogue scale using a 10 cm line which was labelled no pain on the left and worst pain imaginable on the right. 6 Assessments were made immediately before each of the four treatments, and at 5, 10, 15,20,25,30,45,60 minutes and hourly as appropriate after treatment. The duration of analgesia following each treatment was determined as the time interval from injection until the patient requested further analgesia. Respiratory rate and blood pressure (measured by sphygmomanometry) were also recorded before treatment and on at least two occasions within the first 30 minutes following each treatment.
Thirty minutes after each treatment the patients were asked to assess the ease of leg mobility compared with before treatment. Four categories were chosen, q.v. no different, more easily, less easily and not at all. At the same time they were also asked to record any nausea or itchiness on a four point scale, q.v. nil, mild, moderate or severe. Finally an attempt was made to assess the degree of sedation using a linear analogue scale marked fully alert and very drowsy at appropriate ends of a 10 cm line. At the completion of the trial, patients were asked to rank the four treatments in order of preference.
Forced expiratory volume in one second (FE V 1.0) was measured by spirometry (Scitec 4800-B). Three successive readings were recorded before, and thirty minutes after, each treatment. The best of the three readings was used for analysis, and results expressed as a percentage of the pretreatment FEV 1.0.
Venous blood was collected via a three-way tap inserted in an intravenous infusion line to a peripheral forearm vein. Samples were collected just prior to, and approximately 30 minutes after each treatment. All samples were immediately placed in heparinized tubes containing glutathione (5 mmol/litre final concentration) to prevent oxidation of the catecholamines and stored on ice. The tubes were centrifuged on completion of sampling and the plasma decanted and stored at -20 QC until the assay was performed, always within two weeks. The assay measured the plasma concentration of adrenaline, noradrenaline and dopamine by a modification of the radioenzymatic method of Da Pravda and Zurcher. 7 Briefly, this uses tri tiated-S-adenosyl methionine dopamine as a methyl donor for O-methylation of the adrenaline and noradrenaline. The products are separated by thin layer chromatography. The lower limit of detection of the assay for each of the three catecholamines was 0.02 pmol/ml, with an overall coefficient of variation of 110,10 at very low concentrations to 5% at and above the concentration found in this study.
Statistical Analysis
Duration of analgesia and FEV 1.0 were analysed by a one-factor analysis of variance with repeated measures 8 using the Greenhouse-Geisser E-adjusted F-test 9 • If the F-test showed significant (p <0.05) treatment effects, multiple comparisons were made using Tukey's HSD (honestly significant difference) test 8 • Pain scores were summed over the 10-30 minute period after each treatment and analysed in a similar manner, except that a square root transformation was required to bring about approximate normality.
Patient preference were analysed by Friedman's test. JO Where significant (p <0.05) treatment effects were found, multiple comparisons were made using the large sample approximation described by Hollander and Wolfe (1973 
RESULTS
Four patients were withdrawn from the trial. These included one patient who did not request or require any analgesia following tubal microsurgery. The other three patients did not wish to complete the trial, and withdrew at various stages. The remaining nineteen subjects who completed the study are included in the analysis of the results. These included 11 caesarean sections, 7 tubal microsurgical cases and one abdominal hysterectomy.
Although the four treatments were given blindly and in random order, subsequent examination showed that there was in fact an uneven distribution of treatment sequences. For example, intramuscular pethidine was given more frequently as an early treatment whilst both the active epidural drugs were given towards the end of the trial (Table I) .
Pain Relief
The mean sum of pain scores at 10, 15,20,25 and 30 minutes (i.e. maximum possible score = 50) after each treatment for placebo, intramuscular pethidine (im P) epidural bupivacaine (ep B) and epidural pethidine (ep P) were 21.8 (SD 1O.9), 11.8 (SD 8.4), 7.2 (SD 6.2) and 3.9 (SD 3.6) respectively ( All active drugs were better than placebo (p <0.05, Tukey's HSD test~ and ep P 50 mg was superior to im P 100 mg (p <0.05). The time course of analgesia in the first 30 minutes following each treatment is shown in Figure 2 . In this diagram the mean pain scores are plotted as a percentage of the initial score before each treatment. (The mean pre-treatment pain score and range were 6.4 (3-9) 6.6 (5-9), 6.5 (4-10) and 6.9 (4-9) for placebo, im P, ep Band ep P respectively. These pain scores are not significantly different}.
There was no significant difference in the duration of analgesia between the three active treatments as determined by the time interval for patient request for further analgesia. A mean duration of 2Y2-3 hr analgesia was achieved with each of the active treatments ( Figure 3) . Other subjective results Five patients complained of a moderate degree of nausea, three following ep B and two after ep P. One of the subjects also had a mild degree of nausea following placebo and im P. Actual vomiting did not occur following any of the treatments.
One patient on direct questioning had a brief period of moderate itch following ep P, and seven others had mild itch (four after im P, two after ep P and one after placebo).
The degree of mobility 30 minutes after each treatment is shown in Table 2 . These findings are not suitable for statistical analysis, but it may be noted that leg mobility was reduced more frequently following ep B.
Subjective assessment of alertness at 30 minutes after each treatment (zero score = fully alert) was 4.8, 7.0, 3.7 and 5.5 for placebo, im P, ep Band ep P respectively. The range however was so large both between patients and between different treatments in the same patient, that a statistically significant difference among treatments was not achieved.
When the four treatments were ranked in order of preference, all active treatments were preferred over placebo (p <0.05 using the multiple comparison procedure of Hollander and Wolfe'~ and ep P was preferred over all others (Figure 4 ). This preference was statistically significant. In fact ep P was ranked first in fifteen out of eighteen patients. Im P was preferred in three subjects and one patient had no preference for any of the treatments. Objective Measurements There was no change in respiratory rate with any of the treatments. Maximum mean changes in systolic blood pressure for placebo, im P, ep Band ep P were 8 (SD 5), 1 (SD 11), -6 (SD 13) and -1 (SD 13) mm Hg respectively. These changes are small and of no clinical significance.
An improvement in the mean FEV 1.0 30 minutes after treatment of approximately 18070 occurred following both ep Band ep P. But there was a very wide range and these changes did not reach statistical significance ( Figure 5 ). 
Catecholamine Results
The changes in plasma catecholamine levels 30 minutes after each treatment are shown in Figure 6 . It was hypothesised that provision of effective analgesia would lead to a decrease in patient stress and a fall in the circulating catecholamine levels. While some patients did demonstrate the latter, in the group as a whole there was no significant directional change in any of the catecholamines measured. DISCUSSION The study of pain, and therefore of measures designed to treat it, is fraught with difficulties. First, by definition, pain is a subjective experience and cannot therefore be measured objectively. Factors such as personality and previous experience influence an individual's appreciation of pain at any particular instant. Second, in the case of postoperative pain the surgical procedure itself influences the degree of pain experienced: some operations are more painful than others. Third, there is a high incidence of placebo response and fourth, evaluation of treatment is notoriously susceptible to observer bias.
We attempted to overcome these difficulties when designing the trial. Patients were selected The anticipated duration of analgesia of each of the three active treatments under investigation seemed to be well suited for a within-patient trial. Each patient therefore acted as her own control. All of the subjects were studied on the day after surgery by the same nurse observer and the trial was completed in all cases within ten hours. The treatments were given double-blind and in random order so that no one drug was favoured over any of the others. As it happened, however, the order was unevenly distributed (Table 1) . Although this was a fortuitous event, it may nevertheless have biased our results. For example, it is possible that as the investigation proceeded the analgesic requirements for each individual patient became less, or alternatively that a progressive 'carry-over' effect occurred so as to favour the latter treatments. While such a bias cannot be excluded, we feel that this is unlikely because there were no significant differences in pain scores immediately before each treatment.
All three drugs in the doses used in this study provided postoperative analgesia which was superior to placebo and epidural pethidine was preferred over and above the other treatments. The quality of pain relief provided by epidural pethidine was also significantly superior to the intramuscular route, despite the dose being halved. This supports the concept of a selective spinal analgesic action 11 which is distinct from effects which are secondary to circulatory absorption. Furthermore, epidural pethidine provided a degree of analgesia which was at least as good as 0.250/0 bupivacaine. In our experience, epidural bupivacaine does not always provide satisfactory postoperative analgesia. One of us has previously reported that as many as a third of patients described their pain postoperatively as being severe or unbearable following caesarean section despite bupivacaine being available on demand. 12 Unilateral block, missed segments or tachyphylaxis may have accounted for some of these failures. A higher concentration of bupivacaine (e.g. 0.50/0) might have provided better analgesia, but we felt that a dense motor block would not have been acceptable or desirable in our study.
There are certain obvious drawbacks attached to postoperative epidural local analgesia. Even with the weaker concentrations there remains some degree of motor block, and while leg mobility may be retained, it would still not be prudent to allow weight-bearing. In this study our patients were less able to move their legs following bupivacaine and for this reason they were confined to bed during the trial. It is our normal practice however to impose no restrictions on patients who are receiving epidural pethidine postoperatively. Another disadvantage of epidural local anaesthestic agents is the occurrence of hypotension due to autonomic blockade, and while the fall in blood pressure amongst our patients was relatively minor, it is likely that at least some would have developed symptoms of postural hypotension if they had been allowed to stand or sit for example in a chair. Other studies have reported postural hypotension with epidural local anaesthetics. Again this may be contrasted with our usual practice after epidural pethidine of allowing full mobility. Finally, epidural local anaesthesia is associated with difficulties of micturition, which may require continuous or repeated catheterisation of the bladder. In a previous report this occurred among 18070 of patients following caesarean section using bupivacaine 0.25070. 12 A high incidence of bladder dysfunction has, however, also been reported with epidural opioids. But this seems to be more of a problem following epidural morphine, particularly among males. 13 As reported previously we have not witnessed any difficulties with micturition amongst women following caesarean section using epidural pethidine. 14 The above considerations appear to represent significant clinical advantages of epidural pethidine over bupivacaine for postoperative pain relief. There are, however, side effects such as sedation, nausea, pruritus and respiratory depression which may occur following epidural pethidine. While these side effects are common to all opioid drugs, irrespective of the route of administration, there appears to be subtle yet significant and drug-specific differences between the opioid drugs when they are given epidurally. It is not possible, from this study to reach any conclusion about the relative degree of sedation following each of the treatments. Our clinical impression has been that the degree of sedation following epidural pethidine 50 mg is no more apparent than that which accompanies parenterally administered opioids given in similar low therapeutic dosage. This impression is based upon more than 25,000 incremental doses of epidural pethidine for postoperative Anaesthesia and Intensive Care, Vol. 13, No. 2, May, 1985 analgesia. Severe nausea related to epidural pethidine has also been unusual in our experience and, if anything, appears to occur less frequently than following intramuscular pethidine 100 mg. This may be related to the difference in dose requirements by the two routes. Pruritus was recorded on direct questioning during the present study on eight occasions, but this was not associated with any particular treatment. It was in any case of minor importance. There have been, however, several clinical series and case reports of related pruritus reaching a severity such that this method of analgesia has had to be abandoned. It would appear that morphine has again been a more troublesome agent in this respect. 1, 15, 16 As reported previously, we have not found pruritus to be common following epidural pethidine, and it has never been severe enough to discontinue therapy or to require treatment. 14 Discussion so far has centred mainly upon subjective observations made by the patients included in the trial. We attempted to provide a more objective evaluation of analgesic efficacy by using two tests which we felt would indirectly reflect the degree of pain before and after each treatment. The first of these tests, FEV 1.0, measures the volume of air expired in the first second. In order to achieve the highest values of FEV 1.0 it is necessary to use the accessory muscles of expiration, mainly the abdominal muscles. A painful abdominal wound may therefore be expected to reduce FEV 1.0. This has been shown to occur following upper abdominal surgery, I and significant improvement has been demonstrated moreover following efficient analgesia.
In the present study, a mean 18070 improvement in FEV 1.0 occurred over pretreatment readings following both bupivacaine and pethidine given by the epidural route. There was, however, a considerable variance ( Figure 5 ) and a statistically significant difference between the treatments was not demonstrated. There were often widely different values for FEV 1.0 recorded in any group of three successive readings. We did not therefore find the test to be reproducible enough to represent a reliable index of wound pain. These results may reflect the lack of prior training of our patients, or may be due to other factors which might influence FEV 1.0, such as anticipated pain, sedation or loss of concentration. Alternatively, the influence of analgesia on FEV 1.0 may be less demonstrable following lower, as opposed to upper, abdominal surgery.
The other test which we thought might provide an indirect indicator of pain was the level of plasma catecholamines before and after each treatment. Venous plasma levels, particularly of noradrenaline, have been shown to rise in reponse to other stressful conditions,2.5 and we anticipated that postoperative pain and analgesia might also influence the levels of these hormones during our period of study.
Despite this preconception, the various treatments produced no significant directional changes in the levels of any of the three catecholamines measured. Each catecholamine level reflects a balance between sympatho-adrenal release, reuptake into neuronal and extra-neuronal tissues and degradation by specific enzymes. In view of such a dynamic situation, the estimation of a single venous level of noradrenaline as an index of sympathetic activity has been criticised. It might be more relevant in future studies to assess sympathetic nervous system activity by using recently developed kinetic techniques for estimating the rate of release of noradrenaline into the plasma. 17 In one other recent study it has also not been possible to demonstrate any correlation between postoperative pain scores and plasma catecholamine concentrations. 18 We conclude therefore that catecholamine levels per se have no value as indicators of pain or analgesic efficacy in the postoperative period.
